In recent years, exosomes have emerged as promising and sensitive cancer biomarkers for use in disease diagnosis. Exosomes released from cancer cells after entering the circulation are transported in biological fluids along with their functional cargoes. Profiling the nucleic acids of exosomes derived from cancer cells by ultrasensitive next-generation sequencing and proteins by large-scale high-throughput proteomics can help us in early cancer detection, therapeutic stratification, and monitoring patient-specific responses to various cancer therapies. [Read more…]
What is the Current State of Stem Cell Derived Exosomes?
Prior to 2007, exosomes were largely considered to be tiny “trash sacs” thrown out of living cells. Around 2007, it as discovered that exosomes carry RNAs and miRNAs, along with other molecules to regulate the expression of genes between cells. This discovery paved the way for the scientists to search for improved techniques for the exploitation of exosomes in treating diseases. [Read more…]
Taking EV characterization to the next level with ONI’s Nanoimager
Extracellular vesicles (EVs) are known for their role in facilitating wide range of intercellular communication such as regulation of the immune response and stem cells differentiation.
What is an extra-cellular vesicle?
EVs are membrane-enclosed particles ranging in size from 30nm to 300nm and their characteristic depend on the cell type releasing them. Often they will carry cargo of active molecules like RNA, DNA, proteins, metabolites and lipids. Moreover, EVs can be found in most biological fluids with the ability to cross biological barriers, and in the case of pathological conditions, the composition of the cargo will be distinctive to the disease. Altogether, these features have led to intense research into the potential role of EVs for diagnostics, biomarkers and as vehicles for drug delivery. [Read more…]
Top 4 Most Richly Funded Exosome Startups
In recent years, exosome start-up companies have been the recipients of hundreds of millions of dollars in investor funding. Clearly, investors are feeling favorable toward companies developing exosome products and there is a growing belief that the industry is poised for growth. [Read more…]
New Super-Potent Topical Exosome Cosmetics Product, Distributed in UAE by Great Look Medical Supplies, to be Unveiled at Dubai Derma 2023 Conference March 1st- 3rd
ROCHESTER, NY and DUBAI, UAE, Feb. 17, 2023 – On March 1, Resiliélle Cosmetics, LLC and Regenerelle Biotherapeutics will unveil their new Resiliélle brand topical exosome cosmetics product manufactured by Regenerelle and exclusively distributed worldwide by Resiliélle. Resiliélle’s product will set a new standard for skin rejuvenation and lustrous hair. For optimal results, aesthetics professionals may use Resiliélle topically after microneedling or laser treatments. Resiliélle believes that the use of our topical exosome cosmetics will allow MedSpa, Dermatology and Plastic Surgery patients to use Resiliélle topical exosome cosmetics that have been developed to help patients to Leap Back In Time™ — At Any Age.™ [Read more…]
- « Previous Page
- 1
- …
- 4
- 5
- 6
- 7
- 8
- …
- 12
- Next Page »